PlatformQ Health

ClinicalSeriesLive

March 25 through March 31 marks National Physicians’ Week, a time dedicated to recognizing and thanking doctors for the sacrifices they make to take care of all of us. Doctors work tirelessly to help people when they are most in need, and in spite of the important role they play in our lives, they often…

Read More >>


Age-Related macular degeneration (AMD) is one of the most common causes of visual loss in the US. During later stages, visual acuity is worsened due to choroidal neovascularization (CNV) and geographic atrophy (GA). GA occurs when dry AMD becomes advanced.  In early dry AMD, protein deposits, called drusen, are seen scattered on the retina, which…

Read More >>


In this recent CME offering from ClinicalSeriesLive, “The Advancement of Biosimilars: A New Frontier in Medicine, Clinical Applications and Concerns Regarding Biosimilar Products,” viewers gain valuable insight into the testing, approval, and use of biosimilars or treatment of various diseases. As of the production of the video, the only biosimilar approved by the FDA is…

Read More >>


In March of 2015, the FDA approved the first biosimilar for use with American patients. In the next five years, the market is expected to expand to $60 billion in sales in the U.S. and $127 billion worldwide. On February 1st, from 10 am – noon, EST, OMedLive in partnership with ClinicalSeriesLive, will be presenting…

Read More >>